AU4982200A - Antiangiogenic endostatin peptides, endostatin variants and methods of use - Google Patents

Antiangiogenic endostatin peptides, endostatin variants and methods of use

Info

Publication number
AU4982200A
AU4982200A AU49822/00A AU4982200A AU4982200A AU 4982200 A AU4982200 A AU 4982200A AU 49822/00 A AU49822/00 A AU 49822/00A AU 4982200 A AU4982200 A AU 4982200A AU 4982200 A AU4982200 A AU 4982200A
Authority
AU
Australia
Prior art keywords
endostatin
methods
antiangiogenic
variants
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49822/00A
Inventor
Kristiina Vuori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Publication of AU4982200A publication Critical patent/AU4982200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU49822/00A 1999-05-06 2000-05-02 Antiangiogenic endostatin peptides, endostatin variants and methods of use Abandoned AU4982200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13290799P 1999-05-06 1999-05-06
US60132907 1999-05-06
US35333399A 1999-07-14 1999-07-14
US09353333 1999-07-14
PCT/US2000/012063 WO2000067771A1 (en) 1999-05-06 2000-05-02 Antiangiogenic endostatin peptides, endostatin variants and methods of use

Publications (1)

Publication Number Publication Date
AU4982200A true AU4982200A (en) 2000-11-21

Family

ID=26830854

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49822/00A Abandoned AU4982200A (en) 1999-05-06 2000-05-02 Antiangiogenic endostatin peptides, endostatin variants and methods of use

Country Status (2)

Country Link
AU (1) AU4982200A (en)
WO (1) WO2000067771A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010394A1 (en) * 2001-02-27 2002-08-27 Univ Degli Studi Milano PEPTIDES WITH ANTIANGIOGENIC ACTIVITY
DE602004015142D1 (en) * 2003-08-29 2008-08-28 Childrens Medical Center ANTIANGIOGENIC PEPTIDES FOR TREATING OR PREVENTING ENDOMETRIOSIS
US7524811B2 (en) 2003-08-29 2009-04-28 Children's Medical Center Corporation Anti-angiogenic peptides from the N-terminus of endostatin
ITMI20040364A1 (en) * 2004-02-27 2004-05-27 Francesco Chillemi PEPTIDES WITH ANTIANGIOGENIC AND ANTI-TUMOR ACTIVITY
CN1328289C (en) * 2004-03-16 2007-07-25 哈尔滨医科大学 Endothelium chalone capable of improving antitumor activity with changed structure and its use
EP1640382A1 (en) * 2004-08-16 2006-03-29 Université de Liège Anti-angiogenic peptides
EP2364995A1 (en) 2004-12-23 2011-09-14 Molmed SpA Conjugation product
WO2007076501A2 (en) * 2005-12-23 2007-07-05 The Burnham Institute For Medical Research Endometriosis cell targeting peptide and uses thereof
CN100398557C (en) * 2006-04-05 2008-07-02 中国药科大学 Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof
WO2011050311A1 (en) 2009-10-22 2011-04-28 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of endostatin peptides for the treatment of fibrosis
JP6336389B2 (en) * 2011-09-09 2018-06-06 チンファ ユニヴァーシティＴｓｉｎｇｈｕａ Ｕｎｉｖｅｒｓｉｔｙ Endostatin mutant having mutation at ATP binding site
CN108623692B (en) 2017-03-20 2020-11-17 徐寒梅 Fusion protein, preparation method and application thereof
CN108191969B (en) * 2018-01-19 2021-01-01 渤海大学 Two ACE inhibitory peptides derived from Atlantic trout collagen
MX2019013819A (en) * 2019-11-20 2021-05-21 Univ Mexico Nac Autonoma Angiogenesis inhibitory oligopeptides and vascular function.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061693A (en) * 1989-07-28 1991-10-29 Merck & Co., Inc. Fibrinogen receptor antagonists
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis

Also Published As

Publication number Publication date
WO2000067771A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU5774200A (en) Intelligent splitter, system, and methods of use
AU2513400A (en) Authentication system and process
AU3884701A (en) Cardiac methods and system
AU3570799A (en) Titanium-containing catalyst composition and processes therefor and therewith
AU5639900A (en) Shaped scalpel
AU6529900A (en) Novel cloning methods and vectors
AU1812001A (en) Cotton transcription factors and their uses
AU1540001A (en) Fluorene-perylene copolymers and uses thereof
AU2923301A (en) Polymerization catalyst and process
AU715620C (en) Therapeutic methods and uses
AU4982200A (en) Antiangiogenic endostatin peptides, endostatin variants and methods of use
AU6625400A (en) Catalyst preparation and epoxidation process
AU5886500A (en) Indolyl-benzimidazole antibacterials, and methods of use thereof
AU1467101A (en) Myb transcription factors and uses thereof
AU5724000A (en) Anastomosis system and methods for use
AU4484400A (en) Prostate-specific polynucleotides, polypeptides and their methods of use
AU3075200A (en) Telephone and telephone system
AU5296500A (en) User support system and method
AUPP924799A0 (en) Improved separator and process
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
EP1194548A4 (en) Novel pyrrhocoricin-derived peptides, and methods of use thereof
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU2360501A (en) Search system and methods
HK1042901A1 (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
AUPQ180499A0 (en) Beta-amyloid peptide inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase